Condition: Pain, Postoperative · Sponsor: BioQ Pharma, Inc.
This study evaluates a Ropivacaine 0.2% Pre-Filled Dispenser in the treatment of post-surgical pain in patients undergoing Cesarean delivery. Half of the patients will receive Ropivicaine and half will receive placebo.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Clinical Research Associates, Inc. | Birmingham, Alabama, United States | — |
| Shoals Medical Trials, Inc. | Sheffield, Alabama, United States | — |
| University of California, Irvine | Orange, California, United States | — |
| Vision Clinical Research | Wellington, Florida, United States | — |
| Clinical Research Prime | Idaho Falls, Idaho, United States | — |
| MedPharmics, LLC | Biloxi, Mississippi, United States | — |
| Duke University Medical Center | Durham, North Carolina, United States | — |
| Compass Clinical Trial | Beaumont, Texas, United States | — |
| Physician's Research Options, LLC- Corner Canyon OB/GYN | Draper, Utah, United States | — |
| Health Sciences Center- University of Utah | Salt Lake City, Utah, United States | — |
| West Virginia University | Morgantown, West Virginia, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02959476